Harry K.

Harry K. is an experienced finance professional currently serving as Chief Financial Officer at Indication BioScience since January 2023 and as an Equity Partner at PassEntry since November 2022. In addition, Harry K. plays a role on the Board of Advisors for Crusoe, starting in November 2023. Prior to these positions, Harry K. held the role of Managing Director at Barclays Investment Bank from August 2004 to October 2022 and worked in Investment Banking at Schroder Salomon Smith Barney for a brief period in June 2000. Harry K. obtained an Honours degree in Economics from Durham University, following education at Kings College School - Wimbledon.